Anthera Pharmaceuticals Shares Up 37.3% As Roth Capital Initiated Coverage With Buy Rating And $10.00 Price Target; BZ NOTE: Price Target Represents Nearly 500% Possible Price Appreciation From Where Stock Closed Tues.